Wednesday, May 27, 2026
ADVT 
International

US issues record-high 1.4 mn visas to Indians in 2023

Darpan News Desk IANS, 29 Jan, 2024 01:57 PM
  • US issues record-high 1.4 mn visas to Indians in 2023

New Delhi, Jan 29 (IANS) Bringing down the visitor visa appointment wait times by 75 per cent, the US Consular Team in India processed a record-smashing 1.4 million US visas in the year 2023.

Stating that the demand across all visa classes was unprecedented -- with a 60 per cent increase in applications compared to 2022 -- the US Embassy and Consulates said on Monday that Indians now represent one out of every 10 US visa applicants around the world.

In addition, visitor visas (B1/B2) rebounded to represent the second-highest number of applications in the US Mission’s history -- over 700,000.

The US Embassy and Consulates said that it met this demand through a three-month staffing surge in Mumbai early in the year, by increased permanent staff levels, and through the employment of innovative technical solutions.

"Process improvements and investments in staffing have brought the appointment wait time for visitor visas down from an average of 1,000 days to only 250 days around the country. Wait times are minimal in all other categories," the statement read.

Last year, the US consular team in India issued over 140,000 student visas -- more than in any other country in the world setting a record for the third year in a row.

As of now, Mumbai, New Delhi, Hyderabad, and Chennai stand as the top four student visa processing posts in the world.

With these surging numbers, Indian students have become the largest group of international graduate students in the United States and make up more than a quarter of the over one million foreign students studying in the country.

Stating that employment visas remain a top priority, the Embassy stated that in 2024, a pilot program will allow eligible H-1B holders to renew their visas in the United States, further streamlining the process for this group.

Further, Consular Team India consolidated most petition-based visa processing in Chennai and Hyderabad to increase efficiency.

This led to the processing of over 380,000 employment visas for Indians and their family members in 2023 and allowed the US Mission to maintain a minimal appointment wait time.

The Consulate General Mumbai eliminated a queue of over 31,000 immigrant visa cases delayed by the Covid-19 pandemic.

"Those who have a pending immigrant visa petition and are ready for scheduling can now obtain an appointment within the standard, pre-pandemic appointment window," the Embassy stated.

MORE International ARTICLES

Trump supporters mass in D.C. as Biden era begins

Trump supporters mass in D.C. as Biden era begins
Several Republican lawmakers will formally object to president-elect Joe Biden's win, citing phoney allegations of election fraud — a futile exercise that will likely do little beyond delaying the inevitable.

Trump supporters mass in D.C. as Biden era begins

Fauci: US could soon give 1 million vaccinations a day

Fauci: US could soon give 1 million vaccinations a day
Vaccinations have already begun speeding up, reaching roughly half a million injections a day, he pointed out.

Fauci: US could soon give 1 million vaccinations a day

Trump call ratchets up political tension in U.S.

Trump call ratchets up political tension in U.S.
That demand is sure to reverberate Tuesday, when two run-off elections in Georgia will decide whether Democrats or Republicans control the Senate.

Trump call ratchets up political tension in U.S.

'Relieved': US health workers start getting COVID-19 vaccine

'Relieved': US health workers start getting COVID-19 vaccine
Shipments of precious frozen vials of vaccine made by Pfizer Inc. and its German partner BioNTech began arriving at hospitals around the country Monday.

'Relieved': US health workers start getting COVID-19 vaccine

U.K. approves Pfizer coronavirus vaccine for emergency use, this allows England to be one of the 1st countries to begin vaccinating its population

U.K. approves Pfizer coronavirus vaccine for emergency use, this allows England to be one of the 1st countries to begin vaccinating its population
The go-ahead for the vaccine developed by American drugmaker Pfizer and Germany's BioNTech comes as the virus surges again in the United States and Europe, putting pressure on hospitals and morgues in some places and forcing new rounds of restrictions that have devastated economies.

U.K. approves Pfizer coronavirus vaccine for emergency use, this allows England to be one of the 1st countries to begin vaccinating its population

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent
Announcing the results on Monday, Moderna said it has submitted emergency use authorisation from the US Food and Drug Administration (FDA), to apply for a conditional marketing authorisation with the European Medicines Agency (EMA) and to progress with the rolling reviews, which have already been initiated with international regulatory agencies.

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent